Terms: = Lung cancer AND FAT1, CDHF7, 2195, ME5, hFat1, CDHR8 AND Treatment
13 results:
1. Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies.
Liu Q; Zhang J; Guo C; Wang M; Wang C; Yan Y; Sun L; Wang D; Zhang L; Yu H; Hou L; Wu C; Zhu Y; Jiang G; Zhu H; Zhou Y; Fang S; Zhang T; Hu L; Li J; Liu Y; Zhang H; Zhang B; Ding L; Robles AI; Rodriguez H; Gao D; Ji H; Zhou H; Zhang P
Cell; 2024 Jan; 187(1):184-203.e28. PubMed ID: 38181741
[TBL] [Abstract] [Full Text] [Related]
2. Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts.
Zhang L; Wang Y; Wang L; Wang M; Li S; He J; Ji J; Li K; Cao L
J Mol Med (Berl); 2024 Jan; 102(1):69-79. PubMed ID: 37978056
[TBL] [Abstract] [Full Text] [Related]
3. Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer.
JiaXin Y; XiaoFeng C; PengFei C; Songchen Z; Ziling L
Medicine (Baltimore); 2023 Jun; 102(26):e34143. PubMed ID: 37390276
[TBL] [Abstract] [Full Text] [Related]
4. Molecular and Clinicopathological Characteristics of lung cancer Concomitant Chronic Obstructive Pulmonary Disease (COPD).
Ma H; Zhang Q; Zhao Y; Zhang Y; Zhang J; Chen G; Tan Y; Zhang Q; Duan Q; Sun T; Qi C; Li F
Int J Chron Obstruct Pulmon Dis; 2022; 17():1601-1612. PubMed ID: 35860812
[TBL] [Abstract] [Full Text] [Related]
5. lung but not brain cancer cell malignancy inhibited by commonly used anesthetic propofol during surgery: Implication of reducing cancer recurrence risk.
Hu C; Iwasaki M; Liu Z; Wang B; Li X; Lin H; Li J; Li JV; Lian Q; Ma D
J Adv Res; 2021 Jul; 31():1-12. PubMed ID: 34194828
[TBL] [Abstract] [Full Text] [Related]
6. Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options.
Modesto A; Siegfried A; Lusque A; Vergez S; Sarini J; Brouchet L; Uro-Coste E; Graff-Cailleaud P; Delord JP
Curr Oncol; 2021 Apr; 28(3):1673-1680. PubMed ID: 33947015
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.
Shang Y; Li X; Liu W; Shi X; Yuan S; Huo R; Fang G; Han X; Zhang J; Wang K; Dou Z; Zhang Y; Zang A; Zhang L
Sci Rep; 2020 Nov; 10(1):20243. PubMed ID: 33219256
[TBL] [Abstract] [Full Text] [Related]
8. The combination of camrelizumab and apatinib obtained ongoing partial remission for a patient with osimertinib-resistant non-small cell lung cancer: case report.
Cong X; Chen J; Zheng W
Ann Palliat Med; 2021 Mar; 10(3):3469-3474. PubMed ID: 33040541
[TBL] [Abstract] [Full Text] [Related]
9. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial.
Palussière J; Chomy F; Savina M; Deschamps F; Gaubert JY; Renault A; Bonnefoy O; Laurent F; Meunier C; Bellera C; Mathoulin-Pelissier S; de Baere T
J Cardiothorac Surg; 2018 Aug; 13(1):91. PubMed ID: 30143031
[TBL] [Abstract] [Full Text] [Related]
10. Docosahexaenoic acid suppresses breast cancer cell metastasis by targeting matrix-metalloproteinases.
Yun EJ; Song KS; Shin S; Kim S; Heo JY; Kweon GR; Wu T; Park JI; Lim K
Oncotarget; 2016 Aug; 7(31):49961-49971. PubMed ID: 27363023
[TBL] [Abstract] [Full Text] [Related]
11. Docosahexaenoic Acid Induces Cell Death in Human Non-Small Cell lung cancer Cells by Repressing mTOR via AMPK Activation and PI3K/Akt Inhibition.
Kim N; Jeong S; Jing K; Shin S; Kim S; Heo JY; Kweon GR; Park SK; Wu T; Park JI; Lim K
Biomed Res Int; 2015; 2015():239764. PubMed ID: 26339598
[TBL] [Abstract] [Full Text] [Related]
12. An innovative rapid response radiotherapy program to reduce waiting time for palliative radiotherapy.
Danjoux C; Chow E; Drossos A; Holden L; Hayter C; Tsao M; Barnes T; Sinclair E; Farhadian M
Support Care Cancer; 2006 Jan; 14(1):38-43. PubMed ID: 15856333
[TBL] [Abstract] [Full Text] [Related]
13. Decreased n-6/n-3 fatty acid ratio reduces the invasive potential of human lung cancer cells by downregulation of cell adhesion/invasion-related genes.
Xia SH; Wang J; Kang JX
Carcinogenesis; 2005 Apr; 26(4):779-84. PubMed ID: 15661810
[TBL] [Abstract] [Full Text] [Related]
